Insights and impacts from the TALOS-AMI Trial
Watch Prof. Dirk Sibbing discussing key takeaways from the TALOS-AMI trial data released at the LBT session.
.jpg0/jcr:content/image%20(2).jpg)
574835_-_V2_Dirk_Sibbing_-_Insights_and_Impacts_
.webp/jcr:content/dapt-thumb%20(1).webp)
MAT-BH-2300392/V1/JUN2023
Campus
Watch Prof. Dirk Sibbing discussing key takeaways from the TALOS-AMI trial data released at the LBT session.
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.